Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
XPH
60
HOLDINGS
27%
ALSO IN SBIO
SBIO
87
HOLDINGS
20%
ALSO IN XPH
SECTOR DRIFT (XPH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 3.7% | 4.6% | 3.7% |
|
DEFINIUM THERAPEUTICS INC | 2.9% | 2.5% | 2.5% |
|
EDGEWISE THERAPEUTICS, INC. | 1.8% | 2.3% | 1.8% |
|
MBX BIOSCIENCES INC | 3.1% | 1.6% | 1.6% |
|
TARSUS PHARMACEUTICALS, INC. | 1.5% | 1.4% | 1.4% |
XPH Overweight Relative to SBIO
|
ENLIVEN THERAPEUTICS, INC. | 2.2% |
|
ALUMIS INC | 2.1% |
|
TREVI THERAPEUTICS, INC. | 2.1% |
|
HARROW INC | 2.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.8% |
|
LIGAND PHARMACEUTICALS-CL B | 1.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 1.8% |
|
CORCEPT THERAPEUTICS INC | 1.7% |
|
ELANCO ANIMAL HEALTH, INC. | 1.7% |
|
VIATRIS, INC. | 1.6% |
XPH Underweight Relative to SBIO
|
APOGEE THERAPEUTICS, INC. | -4.4% |
|
CG ONCOLOGY, INC. | -3.3% |
|
DIANTHUS THERAPEUTICS INC | -3.0% |
|
ORUKA THERAPEUTICS INC | -2.9% |
|
TRAVERE THERAPEUTICS, INC. | -2.8% |
|
ACADIA PHARMACEUTICALS INC | -2.3% |
|
RELAY THERAPEUTICS, INC. | -2.3% |
|
DYNE THERAPEUTICS INC | -2.1% |
|
NEWAMSTERDAM PHARMA CO NV | -1.9% |
|
DENALI THERAPEUTICS INC. | -1.9% |